To determine whether TMEM106A knockdown induces HCC EMT by activating the Erk1/2/Slug signaling pathway, HepG2-shTMEM106A cells were treated with an Erkl/2 inhibitor, FR 180204. The gene discussed is TMEM106A; the disease is hepatocellular carcinoma.